Skip to main content

Table 1 COPD prevalence dataa

From: Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review

Criteria used to define COPD

Country (sample size)

Study population

Ageb(yr)

Prevalence (%)

Symptomsc

    

   Cerveri et al., 2003 [15]

Italy (18,645)

General population

20-44

9.5

   Huchon et al., 2002 [16]

France (14,076)

General population

≥25

4.1

   Cerveri et al., 2001 [17]

16 countries (14,819)

General population

20-44

2.6

Physician reports

    

   Cazzola et al., 2009 [18]

Italy (15,229)

General population

NS

2.5

   Schirnhofer et al., 2007 [19]

Austria (1,258)

General population

≥40

5.6

   Montnemery et al., 2006 [20]

Sweden (3,692)

General population

20-59

3.6

   Hedman et al., 1999 [21]

Finland (3,102)

General population

18-65

3.7

   Montnemery et al., 1998 [22]

Sweden (8,469)

General population

20-59

4.6

   Lundback et al., 1991 [23]

Sweden (6,610)

General population

35-66

4.1

Functional respiratory tests

    

   Miravitlles et al., 2009 [24]

Spain (4,274)

General population

56.6 (10.7)

10.2

   Van Durme et al., 2009 [25]

Netherlands (7,983)

General population

≥55

11.6

   Hansen et al., 2008 [26]

Denmark (4,757)

General population

45-84

12.0

   Bednarek et al., 2008 [27]

Poland (1,960)

Primary care

56.7 (11.6)

9.3

   Roche et al., 2008 [28]

France (4,764)

Health prevention center

59.9 (10.1)

2.6

   Buist et al., 2007 [8]

Austria (1,258)

General population

≥40

26.1d

 

Germany (683)

  

13.3

 

Poland (526)

  

22.1

 

Norway (638)

  

18.8

   Shahab et al., 2006 [29]

United Kingdom (8,215)

General population

55.5 (13.5)

13.3

   Stavem et al., 2006 [30]

Norway (1,619)

Occupational cohort

49.8 (5.5)

16.4

   Sichletidis et al., 2005 [31]

Greece (6,112)

General population

21-80

5.6

   Murtagh et al., 2005 [32]

Ireland (2,484)

General population

53.3 (8.6)

6.3

   Tzanakis et al., 2004 [33]

Greece (888)

General population

≥35

8.4

   Hasselgren et al., 2001 [34]

Sweden (4,814)

General population

43 (14.8)

2.1

   Peña et al., 2000 [35]

Spain (3,978)

General population

40-69

9.1

   Viegi et al., 2000 [36]

Italy (1,727)

General population

≥25

11.0 or 18.3

   Jaen et al., 1999 [11]

Spain (497)

General population

20-70

7.2

   Dickinson et al., 1999 [37]

United Kingdom (353)

General population

68.25

9.9

   Marco Jordán et al., 1998 [12]

Spain (460)

General population

40-60

6.8

   Renwick & Connolly, 1996 [38]

United Kingdom (783)

General practitioner

66.1

9.0

   Brotons et al., 1994 [13]

Spain (642)

General population

35-65

6.4

   Bakke et al., 1991 [39]

Norway (1,275)

General population

42 (16.1)

4.5

Models

    

   Peabody et al., 2005 [40]

Spain

Total population

≥30

6.2

 

Norway

  

6.3

 

Poland

  

6.7

   Feenstra et al., 2001 [41]

Netherlands

Total population

≥20

1.5

   Stang et al., 2000 [42]

Spain

Total population

≥45

10.3

 

Italy

  

11.1

 

France

  

10.4

 

United Kingdom

  

15.0

  1. aPrevalence estimates are based on symptoms (cough and sputum at least 3 months each year), physician reports, functional respiratory tests (FEV1/FVC ratio <70%, FEV1 <80% of predicted, FEV1/FVC ratio <65%, FEV1/FVC ratio <70% or FEV1/FVC ratio <88% (male)/89% (female)) and models (general population). bAge was reported in various ways distinguished here as follows: "≥ x", minimum age; "x" or "x (y)", mean age or mean age (SD); "x-y", age range i.e. min-max. cThese patients had chronic bronchitis. dThese data are also reported in Schirnhofer et al., 2007 [19]. Abbreviations used: COPD, chronic obstructive pulmonary disease; NS, not specified; FEV1, maximum expiratory volume in 1 second; FVC, forced vital capacity.